5 hrs ago | BioSpace
IMPAX Laboratories, Inc. Board Steps in to Oversee Hayward Manufacturing Issues
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! HAYWARD, Calif.
9 hrs ago | The Washington Post
Teva Bets on Reformulating Drugs as Investors Say - Show Me'
Teva Pharmaceutical Industries Ltd., which just two years ago was analysts' highest-rated stock among the world's 20 biggest drugmakers, is struggling to convince investors that a key part of its strategy will revive growth.
13 hrs ago | Business Journal
Court rules in favor of Mylan in patent case
An appellate court has upheld five patents for Mylan Specialty L.P., reversing a district court's summary judgment affecting the company's Perforomist medication, which is used to treat breathing problems.
18 hrs ago | Business Journal
Mylan Pharmaceuticals has started shipping fenofibrate tablets in two strengths after receiving final approval from the Food and Drug Administration, the Canonsburg company announced.
22 hrs ago | Seeking Alpha
Bristol Myers Squibb And The New Wave Of Cancer Drugs
Even with the best cancer drugs, doctors are forced to switch from one therapy to the next as the tumors rapidly develop resistance.
Takeda And Lundbeck Present Results From Pivotal Phase 3 Clinical...
Takeda Pharmaceutical Company Limited and H. Lundbeck A/S today announced that the companies will be presenting new data from four studies that evaluated effectiveness in treating the overall symptoms of depression in patients taking vortioxetine, an investigational agent under review with the U.S. Food and Drug Administration for the treatment of ... (more)
Pesticide Makers Seek Answers as Bee Losses Sting Agriculture
Monsanto Co is hosting a "Bee Summit." Bayer AG is breaking ground on a "Bee Care Center." And Sygenta AG is funding grants for research into the accelerating demise of honeybees in the United States, where the insects pollinate fruits and vegetables that make up roughly a quarter of the American diet.
Ireland Welcomes Watson Pharmaceuticals, an American Success
Watson Pharmaceuticals , founded by a Taiwanese immigrant in the early 1980s and now a rival to generic drug giants Teva Pharmaceuticals On Monday, Watson capped its intercontinental move when the company announced a $8.5 billion deal to buy Dublin-based- Warner Chilcott .
Breakup of physician, drug company relationship could improve health care, cut cost
A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, more costly and often unnecessary prescription drugs.
Chinese pharma companies look West
Zhejiang Hisun Pharmaceutical Co's pavilion at a fair in Beijing. By setting up a joint venture with US-based Pfizer Inc in September, Hisun made a breakthrough in China's pharmaceutical industry by taking a controlling stake in the JV with Pfizer, the world's largest drug-maker by sales.
DealBook: Actavis to Buy Warner Chilcott in All-Stock Deal
The generic drug maker Actavis agreed on Monday to buy Warner Chilcott , a smaller rival, for about $5 billion in stock, in the latest flurry of deal-making in the specialty drug industry.
Strategic Move To Strengthen Consumer Care Business: Bayer To Acquire ...
Bayer signed an agreement Thursday to acquire 100% of the shares of Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany, a privately held pharmaceutical company specializing in pharmacy-only herbal medicines.
The Fortunate 50: Top execs in region averaged $6.7 million in 2012
Mylan's Robert J. Coury is the highest-paid executive at public companies based in the Tri-State region for the third year in a row, easily outdistancing PPG Industries' Charles E. Bunch, who finished second.
Heard Off the Street: More companies are listening to shareholder concerns over executive pay
Shareholder votes on executive pay mandated by the sweeping Dodd-Frank financial markets overhaul legislation enacted in 2010 are changing how public companies compensate their top executives.
A little-known federal program widely used in Memphis to provide hospitals and health centers that treat the nation's most vulnerable patients with hefty discounts on outpatient drugs is under scrutiny from Congress, regulators and the pharmaceutical industry.
Bristol-Myers Squibb drug study showed effectiveness against advanced melanoma cancer
Two drugs from Bristol-Myers Squibb Co. shrank tumors in as many as half of patients with advanced melanoma, according to early research that may pave the way for cocktails that trigger the immune system to destroy cancer.
Multivariate Approaches for Powder Characterization
Dynamic testing and advances in shear testing provide better insight into powder physical properties and external variables that affect powder behavior.
Delaware's Unclaimed Property Racket:: John Gotti would be proud
Who would have guessed that the State of Delaware's third largest revenue source would essentially be a mafia-like combination of extortion and theft? That's certainly how it sounds when you read Douglas Lindholm's article in Forbes magazine entitled "Once A Friendly Locale To Business, The Modern State Of Delaware Is A Bully." Under the guise of ... (more)
UK Animal Research Labelling Plan Must Not Put Patients Off Treatment, Says ABPI
New UK proposals to label all drugs as "produced as a result of research on animals" have met with muted response from pharmaceutical industry group, the ABPI.
ILC Dover Receives ISO Class 7 Cleanroom Certification
ILC Dover, the designer and manufacturer of NASA's space suits and a wide range of engineered film and fabric products, announced recently it has received certification for its ISO Class 7 Clean Room.